Seaport Res Ptn Forecasts Weaker Earnings for Ayr Wellness

Ayr Wellness Inc. (OTCMKTS:AYRWF) – Equities research analysts at Seaport Res Ptn cut their Q4 2024 earnings estimates for Ayr Wellness in a report released on Sunday, November 24th. Seaport Res Ptn analyst S. Randhawa now expects that the company will post earnings per share of ($0.26) for the quarter, down from their previous forecast of ($0.24). The consensus estimate for Ayr Wellness’ current full-year earnings is ($1.30) per share. Seaport Res Ptn also issued estimates for Ayr Wellness’ Q1 2025 earnings at ($0.24) EPS, Q2 2025 earnings at ($0.22) EPS, Q3 2025 earnings at ($0.21) EPS, Q4 2025 earnings at ($0.20) EPS and FY2025 earnings at ($0.87) EPS.

A number of other equities research analysts have also recently weighed in on the company. Roth Capital upgraded Ayr Wellness to a “strong-buy” rating in a research note on Friday, November 8th. Roth Mkm lowered their price target on shares of Ayr Wellness from $3.50 to $3.00 and set a “buy” rating on the stock in a report on Thursday, November 14th. Finally, Atb Cap Markets downgraded shares of Ayr Wellness from a “hold” rating to a “strong sell” rating in a research report on Wednesday, November 13th.

Ayr Wellness Stock Up 2.3 %

Ayr Wellness stock opened at $0.71 on Wednesday. Ayr Wellness has a twelve month low of $0.62 and a twelve month high of $4.09. The business has a fifty day moving average of $1.60 and a two-hundred day moving average of $1.89. The firm has a market cap of $81.05 million, a P/E ratio of -0.32 and a beta of 2.00. The company has a quick ratio of 0.58, a current ratio of 1.59 and a debt-to-equity ratio of 0.76.

About Ayr Wellness

Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.